Inari Medical, Inc. (NASDAQ: NARI) reported Q4 EPS of ($0.11), $0.06 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $107.8 million versus the consensus estimate of $103.78 million.

For earnings history and earnings-related data on Inari Medical, Inc. (NARI) click here.